120 related articles for article (PubMed ID: 3307574)
1. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy.
Bush A; Busst C; Knight WB; Shinebourne EA
Am Rev Respir Dis; 1987 Sep; 136(3):767-9. PubMed ID: 3307574
[TBL] [Abstract][Full Text] [Related]
2. The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease.
Bush A; Busst CM; Shinebourne EA
Int J Cardiol; 1985 Nov; 9(3):267-74. PubMed ID: 3902674
[TBL] [Abstract][Full Text] [Related]
3. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
4. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease.
Limsuwan A; Pienvichit P; Khowsathit P
Pediatr Cardiol; 2005; 26(6):787-91. PubMed ID: 16132278
[TBL] [Abstract][Full Text] [Related]
5. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
6. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
Rosenzweig EB; Kerstein D; Barst RJ
Circulation; 1999 Apr; 99(14):1858-65. PubMed ID: 10199883
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory pulmonary arterial hypertension with inhaled epoprostenol in an infant with congenital heart disease.
Kovach J; Ibsen L; Womack M; Steusse D; Law YM
Congenit Heart Dis; 2007; 2(3):194-8. PubMed ID: 18377465
[TBL] [Abstract][Full Text] [Related]
8. Management of pulmonary arterial hypertension associated with congenital heart disease.
Togănel R; Benedek I; Suteu C; Blesneac C
Rom J Intern Med; 2007; 45(3):229-34. PubMed ID: 18333354
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Laohaprasitiporn D; Soongswang J; Chanthong P; Nana A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S60-5. PubMed ID: 16856428
[TBL] [Abstract][Full Text] [Related]
10. [Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow].
Salgado-Escobar JL; Ledesma-Velasco M; Munayer-Calderón J; Núñez-Garduño D; Salas-López ME; Rodríguez-Hernández L
Bol Med Hosp Infant Mex; 1987 Mar; 44(3):137-42. PubMed ID: 3580096
[No Abstract] [Full Text] [Related]
11. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
12. Congenital heart disease and pulmonary hypertension.
Beghetti M
Rev Port Cardiol; 2004 Feb; 23(2):273-81. PubMed ID: 15116461
[No Abstract] [Full Text] [Related]
13. Can pulmonary vasodilator therapy expand the operative indications for congenital heart disease?
Inai K
Int Heart J; 2015; 56 Suppl():S12-6. PubMed ID: 25787792
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation and management of pulmonary hypertension in the adult with congenital heart disease.
Opotowsky AR
Circulation; 2015 Jan; 131(2):200-10. PubMed ID: 25583054
[No Abstract] [Full Text] [Related]
15. Pulmonary arterial hypertension associated with congenital heart disease. Personal perspectives.
Nakanishi T
Int Heart J; 2015; 56 Suppl():S1-3. PubMed ID: 25787791
[TBL] [Abstract][Full Text] [Related]
16. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension in congenital heart diseases.
Beghetti M; Tissot C
Semin Respir Crit Care Med; 2009 Aug; 30(4):421-8. PubMed ID: 19634081
[TBL] [Abstract][Full Text] [Related]
18. Congenital heart disease and pulmonary hypertension.
Gupta V; Tonelli AR; Krasuski RA
Heart Fail Clin; 2012 Jul; 8(3):427-45. PubMed ID: 22748904
[TBL] [Abstract][Full Text] [Related]
19. Beraprost sodium for pulmonary hypertension with congenital heart disease.
Suzuki H; Sato S; Tanabe S; Hayasaka K
Pediatr Int; 2002 Oct; 44(5):528-9. PubMed ID: 12225555
[No Abstract] [Full Text] [Related]
20. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
